These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 29492793)

  • 41. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
    J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of thyroid malignancy following an index head and neck squamous cell carcinoma: A population-based study.
    Chan JY; Gooi Z; Mydlarz WK; Agrawal N
    Ear Nose Throat J; 2016 Dec; 95(12):E7-E11. PubMed ID: 27929600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Second malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: A population-based study.
    Zong X; Pole JD; Grundy PE; Mahmud SM; Parker L; Hung RJ
    Eur J Cancer; 2017 Oct; 84():173-183. PubMed ID: 28822326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
    Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB
    J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation and management of a solitary thyroid nodule in a child.
    Bentley AA; Gillespie C; Malis D
    Otolaryngol Clin North Am; 2003 Feb; 36(1):117-28. PubMed ID: 12803013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Second malignancies after childhood noncentral nervous system solid cancer: Results from 13 cancer registries.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Olsen JH; Tracey E; Pukkala E; Weiderpass E; Brewster DH; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    Int J Cancer; 2011 Oct; 129(8):1940-52. PubMed ID: 21520035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Years 1993-2013.
    Milano AF
    J Insur Med; 2018 Jan; 47(3):143-158. PubMed ID: 30192723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
    Silva-Vieira M; Carrilho Vaz S; Esteves S; Ferreira TC; Limbert E; Salgado L; Leite V
    Thyroid; 2017 Aug; 27(8):1068-1076. PubMed ID: 28614983
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Second primary malignancy among cancer survivors - epidemiology, prognosis and clinical relevance].
    Grundmann RT; Meyer F
    Zentralbl Chir; 2012 Dec; 137(6):565-74. PubMed ID: 22426967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.
    Friedman DL; Whitton J; Leisenring W; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL; Neglia JP
    J Natl Cancer Inst; 2010 Jul; 102(14):1083-95. PubMed ID: 20634481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
    Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
    J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of second primary cancers in North Portugal-a population-based study.
    Pacheco-Figueiredo L; Antunes L; Bento MJ; Lunet N
    J Cancer Surviv; 2016 Feb; 10(1):142-52. PubMed ID: 26159159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas.
    Kim C; Bi X; Pan D; Chen Y; Carling T; Ma S; Udelsman R; Zhang Y
    Thyroid; 2013 May; 23(5):575-82. PubMed ID: 23237308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study.
    Lal G; Groff M; Howe JR; Weigel RJ; Sugg SL; Lynch CF
    Ann Surg Oncol; 2012 Jun; 19(6):1887-96. PubMed ID: 22227921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma.
    Kumar V; Garg M; Chandra AB; Mayorga VS; Ahmed S; Ailawadhi S
    Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):576-589.e1. PubMed ID: 29934060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Second malignant neoplasms among children, adolescents and young adults with Wilms tumor.
    Lee JS; Padilla B; DuBois SG; Oates A; Boscardin J; Goldsby RE
    Pediatr Blood Cancer; 2015 Jul; 62(7):1259-64. PubMed ID: 25809878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic factors determining long-term survival in well-differentiated thyroid cancer: an analysis of four hundred eighty-four patients undergoing therapy and aftercare at the same institution.
    Eichhorn W; Tabler H; Lippold R; Lochmann M; Schreckenberger M; Bartenstein P
    Thyroid; 2003 Oct; 13(10):949-58. PubMed ID: 14611704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple primary tumors involving cancer of the brain and central nervous system as the first or subsequent cancer.
    Inskip PD
    Cancer; 2003 Aug; 98(3):562-70. PubMed ID: 12879474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.